Changes in the expression level of IL-17A and p53-fibrinolytic system in smokers with or without COPD

التفاصيل البيبلوغرافية
العنوان: Changes in the expression level of IL-17A and p53-fibrinolytic system in smokers with or without COPD
المؤلفون: Yashodhar P. Bhandary, Irfan Kandhal, Sadiya Bi Shaikh, Ashwini Shetty, Deepu Chengappa, Mahesh Manjunath Gouda
المصدر: Molecular Biology Reports. 45:2835-2841
بيانات النشر: Springer Science and Business Media LLC, 2018.
سنة النشر: 2018
مصطلحات موضوعية: Adult, Male, 0301 basic medicine, medicine.medical_specialty, medicine.medical_treatment, Apoptosis, Disease, Gastroenterology, Pulmonary Disease, Chronic Obstructive, 03 medical and health sciences, 0302 clinical medicine, Western blot, Internal medicine, Plasminogen Activator Inhibitor 1, Genetics, medicine, Humans, Molecular Biology, Aged, COPD, medicine.diagnostic_test, business.industry, Fibrinolysis, Interleukin-17, Smoking, Significant difference, General Medicine, Middle Aged, Control subjects, medicine.disease, Urokinase-Type Plasminogen Activator, respiratory tract diseases, 030104 developmental biology, Cytokine, 030228 respiratory system, Case-Control Studies, Female, Tumor Suppressor Protein p53, Airway, business
الوصف: COPD is a chronic airway inflammatory disease characterized mainly by neutrophil airway infiltrations. The neutrophil airway inflammation is mainly mediated through a key player like the pro-inflammatory cytokine IL-17A which is involved in the modulation of p53-fibrinolytic system. This study was undertaken to examine the molecular changes for the expressions of IL-17A and p53-fibrinolytic system in smokers with or without COPD. Blood and serum samples were collected from ten patients of smokers having COPD and ten samples from smokers without COPD and ten healthy control subjects. Western blot analyses were performed to evaluate the expressions of IL-17A, p53 and PAI-1. Apoptosis was assessed by immunoblot for cleaved caspase-3. In addition, FEV% was also determined of these patients. qRT-PCR was done to detect the gene expression study from the blood samples on p53-fibrinolytic components. A significant difference was found in the expression levels of IL-17A in smokers with COPD patient when compared to smokers without COPD and the control subjects. Similarly the smokers with COPD showed significant increase in the fibrinolytic component PAI-1 as well as in expression levels of p53 when compared to smokers without COPD and normal subjects. Increased cleaved caspase-3 may also promote apoptosis.The expression pattern of the IL-17A in chronic obstructive pulmonary distress syndrome samples was increased as compared of those of normal samples, and their main role in the regulation of and p53-fibrinolytic system makes these components as a predictive prominent component in smokers with COPD.
تدمد: 1573-4978
0301-4851
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08a269018e8438eaecb6c0afe2ed979fTest
https://doi.org/10.1007/s11033-018-4398-yTest
حقوق: CLOSED
رقم الانضمام: edsair.doi.dedup.....08a269018e8438eaecb6c0afe2ed979f
قاعدة البيانات: OpenAIRE